1 follower
Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.
Elisabet de los Pinos
Calico
6 followers
Qualigen Therapeutics
3 followers
Vera Therapeutics
2 followers
Cargo
1 follower
Capricor Therapeutics
1 follower
Edgewise Therapeutics
1 follower
Cartesian Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
180 followers
Gilead Sciences
136 followers
Biogen
123 followers
Explore companies